Stromal Cell Derived Factor‐1 (SDF‐1) Targeting Reperfusion Reduces Myocardial Infarction in Isolated Rat Hearts
Authors:
Open Access
- 15 September 2011
- journal article
- review article
- Published by Wiley in Cardiovascular Therapeutics
- Vol. 30 (5) , 264-272
Abstract
SUMMARY: Recent studies have shown that stromal cell derived factor‐1 (SDF‐1), first known as a cytokine involved in recruiting stem cells into injured organs, confers myocardial protection in myocardial infarction, which is not dependent on stem cell recruitment but related with modulation of ischemia‐reperfusion (I/R) injury. However, the effect of SDF has been studied only in a preischemic exposure model, which is not clinically relevant if SDF is to be used as a therapeutic agent. Our study was aimed at evaluating whether or not SDF‐1 confers cardioprotection during the reperfusion period. Hearts from SD rats were isolated and perfused with the Langendorff system. Proximal left coronary artery ligation, reperfusion, and SDF perfusion in KH buffer was done according to study protocol. Area of necrosis (AN) relative to area at risk (AR) was the primary endpoint of the study. Significant reduction of AN/AR by SDF in an almost dose‐dependent manner was noted during both the preischemic exposure and reperfusion periods. In particular, infusion of a high concentration of SDF (25 nM/L) resulted in a dramatic reduction of infarct size, which was greater than that achieved with ischemic pre‐ or postconditioning. SDF perfusion during reperfusion was associated with a similar significant reduction of infarct size as preischemic SDF exposure. Further studies are warranted to assess the potential of SDF as a therapeutic agent for reducing I/R injury in clinical practice.Keywords
This publication has 29 references indexed in Scilit:
- Mesenchymal stem cells over-expressing SDF-1 promote angiogenesis and improve heart function in experimental myocardial infarction in rats☆European Journal of Cardio-Thoracic Surgery, 2009
- Adenovirus-mediated stromal cell-derived- factor-1 gene transfer induces cardiac preservation after infarction via angiogenesis of CD133+ stem cells and anti-apoptosisInteractive CardioVascular and Thoracic Surgery, 2008
- Effect of Cyclosporine on Reperfusion Injury in Acute Myocardial InfarctionNew England Journal of Medicine, 2008
- Time to Take Myocardial Reperfusion Injury SeriouslyNew England Journal of Medicine, 2008
- Clinical Applications of Blood-Derived and Marrow-Derived Stem Cells for Nonmalignant DiseasesJAMA, 2008
- Preconditioning enhances cell survival and differentiation of stem cells during transplantation in infarcted myocardiumCardiovascular Research, 2007
- Myocardial Reperfusion InjuryNew England Journal of Medicine, 2007
- Circulating angiogenic cytokines and stem cells in patients with severe chronic ischemic heart disease — Indicators of myocardial ischemic burden?International Journal of Cardiology, 2007
- Stromal Cell–Derived Factor-1α Plays a Critical Role in Stem Cell Recruitment to the Heart After Myocardial Infarction but Is Not Sufficient to Induce Homing in the Absence of InjuryCirculation, 2004
- Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathyThe Lancet, 2003